What is the ticker symbol for Ocuphire Pharma?

Ocuphire Pharma trades under the ticker OCUP on NASDAQ.

What sector does Ocuphire Pharma operate in?

Ocuphire Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OCUP in a portfolio?

PortView shows OCUP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Ocuphire Pharma (OCUP) Stock Analysis

NASDAQHealthcareBiotechnology

$1.17-12.03%

1-year price historyRange $0.88 – $3.27

52-week range$1.17

$1.07$3.40

What Ocuphire Pharma does

Ocuphire Pharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to researching and bringing to market treatments for various refractive and retinal eye conditions. The company's primary investigational drug is Nyxol eye drops, a preservative-free phentolamine mesylate formulation administered once daily. Nyxol is currently undergoing advanced (Phase III) clinical trials for individuals experiencing difficulties with dim light or night vision. It is also in Phase 2b testing for reversing pharmacologically induced pupil dilation, and has successfully completed its Phase 2 VEGA-1 study for the treatment of presbyopia (age-related farsightedness). Beyond Nyxol, Ocuphire is developing APX3330, an oral tablet taken twice a day. This medication is designed to address key pathways involved in vascular diseases affecting the retina and choroid, including conditions like diabetic retinopathy and diabetic macular edema. Furthermore, the company is exploring APX2009 and APX2014, which are next-generation preclinical drug candidates and analogs derived from APX3330. Ocuphire Pharma, Inc. is based in Farmington Hills, Michigan.

Key metrics

Market cap

$31.74M

P/E (TTM)

-2.17

EPS (TTM)

$-0.54

Beta

0.31

Dividend yield

0.00%

Revenue / share

$0.10

50-day avg

$1.27

200-day avg

$1.74

52-week high

$3.40

52-week low

$1.07

CEO

George Magrath

ETFs linked to OCUP

Broad-market and Healthcare sector ETFs an investor holding Ocuphire Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OCUP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OCUP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Ocuphire Pharma?: Ocuphire Pharma trades under the ticker OCUP on NASDAQ.
Which exchange is OCUP listed on?: OCUP is listed on NASDAQ.
What sector does Ocuphire Pharma operate in?: Ocuphire Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OCUP in a portfolio?: PortView shows OCUP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.